Back to CA Caption Management, LLC

ITCIITCI
17 quarters

Position history for CACaption Management, LLC's holdings in INTRA-CELLULAR THERAPIES INC

No. Caption Management exited its ITCI (Intra-Cellular Therapies) position in Q3 2024. Its Q2 2024 13F listed 618 shares worth $42,327. Caption Management already held ITCI in its Q1 2019 13F, the earliest on record, and held it in 13 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$975,000

Total Shares Change

-80,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q2
Decreased
618
-99.8%
$42,3270.0%—
0
2024-Q1
Increased
266,780
+567.0%
$18.5M0.3%—
55
2023-Q4
New
39,997
-
$2.9M0.0%—
36
2023-Q1
Exited
0
-100.0%
$00.0%—
0
2022-Q4
Increased
12,205
+82.0%
$645,8890.0%—
38
2022-Q3
New
6,705
-
$312,0000.0%—
32
2022-Q1
Exited
0
-100.0%
$00.0%—
0
2021-Q4
Decreased
17,144
-60.5%
$898,0000.0%—
0
2021-Q3
Increased
43,379
+331.2%
$1.6M0.0%—
41
2021-Q2
Increased
10,060
+29.0%
$411,0000.0%—
30
2021-Q1
Decreased
7,800
-75.2%
$265,0000.0%—
0
2020-Q4
Decreased
31,500
-47.2%
$1M0.0%—
0
2020-Q3
Increased
59,673
+12.5%
$1.5M0.0%—
29
2020-Q2
New
53,050
-
$1.4M0.0%—
35
2019-Q2
Exited
0
-100.0%
$00.0%—
0
2019-Q1
First report
80,000
-
$975,0000.1%—
0

Other major holders of ITCI: VANGUARD GROUP INC, BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used